ALLOGENE THERAPEUTICS INC (ALLO)
Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended u
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
